COMMUNIQUÉS West-GlobeNewswire

Kura Oncology Reports First Quarter 2019 Financial Results and Highlights Upcoming Milestones
07/05/2019
– Registration-directed trial of tipifarnib in HRAS mutant HNSCC continues on track – – Data from ongoing Phase 2 trial of tipifarnib in CXCL12-driven PTCL accepted for oral presentations at EHA and ICML next month – – [...]
Kezar Life Sciences Reports First Quarter 2019 Financial Results and Provides Business Update
07/05/2019
Phase 1b systemic lupus erythematosus (SLE) top-line data release and Phase 2 lupus nephritis (LN) initiation on track in Q2 2019 Site selection underway for Phase 2 trial of KZR-616 for the treatment of dermatomyositis [...]
New Long-Term TEGSEDI Safety and Efficacy Data Featured as an Oral Presentation at 2019 American Academy of Neurology Annual Meeting (AAN)
07/05/2019
NEURO-TTR phase 3 open-label extension study showed TEGSEDI ® ( inotersen) treatment continued to slow progression over two-year period in patients with Hereditary ATTR amyloidosis with polyneuropathy Greater efficacy [...]
Myriad Genetics Reports Fiscal Third-Quarter 2019 Financial Results
07/05/2019
Total Third-Quarter Revenues of $216.6 Million, Up 18 Percent Third-Quarter Diluted EPS of $0.09 and Adjusted EPS of $0.46, Up 35 Percent SALT LAKE CITY, May 07, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: [...]
Wright Medical Group N.V. Reports 2019 First Quarter Financial Results
07/05/2019
First Quarter 2019 Net Sales, Including Cartiva ® , of $230 Million, Representing As-Reported Growth of 16%, Constant Currency Growth of 18% and Organic Constant Currency Growth of 13% First Quarter 2019 Record Gross [...]
Fulgent Genetics Reports First Quarter 2019 Financial Results
07/05/2019
First Quarter 2019 Results : Revenue totals $5.4 million, growing 15% year over year Billable tests delivered total 7,530, growing 63% year over year GAAP loss of $1.9 million, or $0.10 per share Non-GAAP loss of $1.0 [...]
Aduro Biotech Reports First Quarter 2019 Financial Results
07/05/2019
BERKELEY, Calif., May 07, 2019 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO), a clinical-stage biopharmaceutical company focused on developing therapies targeting the Stimulator of Interferon Genes (STING) and [...]
Eton Pharmaceuticals Reports First Quarter 2019 Financial Results and Highlights Business Progress
07/05/2019
– Four Products Currently Under Review with the FDA – – Expecting Multiple Product Launches in Second Half of 2019 – – Company to Host Conference Call and Webcast today at 4:30 p.m. ET (3:30 p.m. CT) - DEER PARK, Ill., [...]
Autolus Therapeutics to Report First Quarter 2019 Financial Results and Host Conference Call on May 14
07/05/2019
LONDON, May 07, 2019 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced that it will release [...]
CohBar Reports First Quarter 2019 Financial Results and Business Update
07/05/2019
Company to host conference call and webcast today, May 7, at 5:00 p.m. EDT MENLO PARK, Calif., May 07, 2019 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria [...]
Ascendis Pharma A/S Announces Participation in the Bank of America Merrill Lynch 2019 Healthcare Conference
07/05/2019
COPENHAGEN, Denmark, May 07, 2019 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon™ technologies to address unmet medical needs, today announced [...]
Editas Medicine Announces First Quarter 2019 Results and Update
07/05/2019
- Building on focus in oncology through newly-formed partnership with BlueRock Therapeutics to develop universal allogeneic cell medicines for cancer - - EDIT-101 (AGN-151587) for LCA10 on track for first patient dosing [...]
Retrophin Reports First Quarter 2019 Financial Results
07/05/2019
Top-line results from pivotal Phase 3 FORT Study in PKAN on-track for 3Q 2019 Enrollment ongoing in Phase 3 clinical trials of sparsentan for patients with rare nephropathies FSGS and IgAN Continued quarter over quarter [...]
Principia Biopharma Reports First Quarter Financial Results
07/05/2019
SOUTH SAN FRANCISCO, Calif., May 07, 2019 (GLOBE NEWSWIRE) -- Principia Biopharma Inc. (Nasdaq: PRNB), a late-stage biopharmaceutical company dedicated to bringing transformative oral therapies to patients with [...]
Celldex Provides Corporate Update and Reports First Quarter 2019 Results
07/05/2019
HAMPTON, N.J., May 07, 2019 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today reported business and financial highlights for the first quarter ended March 31, 2019. “Celldex presented positive data [...]
Verrica Pharmaceuticals Reports First Quarter 2019 Financial Results
07/05/2019
-Reported positive topline data from pivotal Phase 3 clinical trials of VP-102 for the treatment of molluscum contagiosum -Preparing to submit NDA in second half of 2019 WEST CHESTER, Pa., May 07, 2019 (GLOBE NEWSWIRE [...]
Novelion Therapeutics Reports First Quarter 2019 Financial Results
07/05/2019
Company reiterates 2019 guidance of total net revenues between $160.0 and $175.0 million, including approximately $30.0 million of licensing revenues VANCOUVER, British Columbia, and CAMBRIDGE, Mass., May 07, 2019 ( [...]
Cara Therapeutics Reports First Quarter 2019 Financial Results
07/05/2019
– Conference call today at 4:30 p.m. ET – STAMFORD, Conn., May 07, 2019 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical [...]
Iovance Biotherapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update
07/05/2019
- First patient dosed in pivotal Cohort 4 in study of lifileucel in advanced melanoma; regulatory submission planned for late 2020 - - New interim data from melanoma Cohort 2 and cervical cancer studies to be presented [...]

Pages